Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rachida S. Bel Aiba"'
Autor:
Shane A. Olwill, Veronique Blanc, Christine Rothe, Rachida S. Bel Aiba, Markus Zettl, Maximilien Grandclaudon, Matthieu Riviere, Celine Sancerne, Birgit Bossenmaier, Alix Scholer-Dahirel, Helene Lelievre, Marleen Richter, Eva-Maria Hansbauer, Catherine Gallou, Thomas J. Jaquin, Aizea Morales-Kastresana, Lucia Pattarini, Marina Pavlidou, Janet K. Peper-Gabriel
Supplementary Table from The PD-L1/4-1BB Bispecific Antibody–Anticalin Fusion Protein PRS-344/S095012 Elicits Strong T-Cell Stimulation in a Tumor-Localized Manner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09683939ca1968a7429fc3bd2a7978ed
https://doi.org/10.1158/1078-0432.22482120.v1
https://doi.org/10.1158/1078-0432.22482120.v1
Autor:
Shane A. Olwill, Veronique Blanc, Christine Rothe, Rachida S. Bel Aiba, Markus Zettl, Maximilien Grandclaudon, Matthieu Riviere, Celine Sancerne, Birgit Bossenmaier, Alix Scholer-Dahirel, Helene Lelievre, Marleen Richter, Eva-Maria Hansbauer, Catherine Gallou, Thomas J. Jaquin, Aizea Morales-Kastresana, Lucia Pattarini, Marina Pavlidou, Janet K. Peper-Gabriel
Supplementary Figure from The PD-L1/4-1BB Bispecific Antibody–Anticalin Fusion Protein PRS-344/S095012 Elicits Strong T-Cell Stimulation in a Tumor-Localized Manner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03beeeee9f6afdb49943e64a9999656f
https://doi.org/10.1158/1078-0432.22482126
https://doi.org/10.1158/1078-0432.22482126
Autor:
Shane A. Olwill, Veronique Blanc, Christine Rothe, Rachida S. Bel Aiba, Markus Zettl, Maximilien Grandclaudon, Matthieu Riviere, Celine Sancerne, Birgit Bossenmaier, Alix Scholer-Dahirel, Helene Lelievre, Marleen Richter, Eva-Maria Hansbauer, Catherine Gallou, Thomas J. Jaquin, Aizea Morales-Kastresana, Lucia Pattarini, Marina Pavlidou, Janet K. Peper-Gabriel
Purpose:While patients responding to checkpoint blockade often achieve remarkable clinical responses, there is still significant unmet need due to resistant or refractory tumors. A combination of checkpoint blockade with further T-cell stimulation me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e18ed00c28b4f873d320cdf7bc8fa20
https://doi.org/10.1158/1078-0432.c.6530826
https://doi.org/10.1158/1078-0432.c.6530826
Autor:
Janet K. Peper-Gabriel, Marina Pavlidou, Lucia Pattarini, Aizea Morales-Kastresana, Thomas J. Jaquin, Catherine Gallou, Eva-Maria Hansbauer, Marleen Richter, Helene Lelievre, Alix Scholer-Dahirel, Birgit Bossenmaier, Celine Sancerne, Matthieu Riviere, Maximilien Grandclaudon, Markus Zettl, Rachida S. Bel Aiba, Christine Rothe, Veronique Blanc, Shane A. Olwill
Publikováno v:
Clinical Cancer Research. 28:3387-3399
Purpose:While patients responding to checkpoint blockade often achieve remarkable clinical responses, there is still significant unmet need due to resistant or refractory tumors. A combination of checkpoint blockade with further T-cell stimulation me
Autor:
Gabriele Matschiner, Mary F. Fitzgerald, Ulrich Moebius, Andreas M. Hohlbaum, Hendrik Gille, Kristian Jensen, Klaus Kirchfeld, Barbara Rattenstetter, Alice Laforge, Rachida S. Bel Aiba, Joe Ciccotosto, Hong Nyugen, Martyn L. Foster, John N. Snouwaert, MyTrang Nguyen, Beverly H. Koller, Louis Matis, Gary P. Anderson, Shane A. Olwill
Publikováno v:
The Journal of allergy and clinical immunology.
T2 endotype asthma is driven by IL-4 and IL-13 signaling via IL-4Ra, which is highly expressed on airway epithelium, airway smooth muscle and immunocytes in the respiratory mucosa, suggesting potential advantages of an inhalable antagonist. Lipocalin